Research programme: small molecule SHIP modulators - Aquinox Pharmaceuticals

Drug Profile

Research programme: small molecule SHIP modulators - Aquinox Pharmaceuticals

Alternative Names: AQX-016A; AQX-100; AQX-100 series; AQX-1000 series; AQX-200 series; AQX-252; AQX-273; AQX-278; AQX-300 series; AQX-356; AQX-MN100; AQX-MN106; AQX-MN278; AQX-SHIP inhibitors; AXQ C5; SHIP1 inhibitors

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Aquinox Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Inositol-1,4,5-trisphosphate 5 phosphatase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Haematological disorders; Haematological malignancies; Immunological disorders; Inflammation
  • Discontinued Allergic conjunctivitis; Dry eyes

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Haematological-malignancies in Canada
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in Canada
  • 04 Nov 2017 No recent reports of development identified for research development in Haematological-disorders in Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top